§ 48-842.01. Short title.

Current through October 23, 2012

This chapter may be cited as the "Medication Advisory Committee Receiving Gifts or Remuneration Prohibition Act of 2008".

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 301, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

Law 17-131, the "SafeRx Amendment Act of 2008", was introduced in Council and assigned Bill No. 17-364 which was referred to the Committee on Health. The Bill was adopted on first and second readings on December 11, 2007, and January 8, 2008, respectively. Signed by the Mayor on February 1, 2008, it was assigned Act No. 17-282 and transmitted to both Houses of Congress for its review. D.C. Law 17-131 became effective on March 26, 2008.

§ 48-842.02. Definitions.

Current through October 23, 2012 Back to Top

For the purposes of this chapter, the term:

(1) "Medication advisory committee" means any committee or panel that is responsible for making recommendations or decisions regarding a formulary to be used by a health program administered by the government of the District of Columbia.

(2) "Pharmaceutical company" means any entity that is engaged in, either directly or indirectly, the production, preparation, propagation, compounding, manufacturing, conversion or processing of a drug or biological product, including any person acting as its agent or representative.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 302, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-842.01.

§ 48-842.03. Prohibition on gifts and remuneration.

Current through October 23, 2012 Back to Top

(a) A pharmaceutical company shall not offer a gift or remuneration of any kind to a member of a medication advisory committee.

(b) A member of a medication advisory committee shall not accept a gift or remuneration of any kind from a pharmaceutical company.

(c) Nothing in this section shall prohibit the offering or acceptance of medication samples to members of a medication advisory committee who are licensed physicians engaged in the practice of medicine.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 303, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-842.01.

§ 48-842.04. Penalties.

Current through October 23, 2012 Back to Top

A violation of this chapter shall be punishable by a fine of $1,000 per violation.

                
                    var val = document.getElementById('citecontent').innerHTML;
                    art.dialog.defaults.title = window.location.href;
                    art.dialog.data('cite', val);
                    art.dialog.data('homeDemoPath', '/Scripts/plus/artDialog/');
                    art.dialog.open('/Scripts/plus/artDialog/citeiframe.html');

(Mar. 26, 2008, D.C. Law 17-131, § 304, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-843.01.